Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway

• Main Authors: Ren T (Author), Shan J (Author), Qing Y (Author), Qian C (Author), Li Q (Author), Lu G (Author), Li M (Author), Li C (Author), Peng Y (Author), Luo H (Author), Zhang S (Author), Zhang W (Author), Wang D (Author), Zhou SF (Author)
• Format: Book
• Published: Dove Medical Press, 2014-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Tao Ren,1,2,* Jinlu Shan,1,* Yi Qing,1 Chengyuan Qian,1 Qing Li,1 Guoshou Lu,1 Mengxia Li,1 Chongyi Li,1 Yu Peng,1 Hao Luo,1 Shiheng Zhang,1 Weiwei Zhang,1 Dong Wang,1 Shu-Feng Zhou3 1Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, Peop...